Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C

Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation

(2014) Michael T. Dill et al.   JOURNAL OF CLINICAL INVESTIGATION

Occult Hepatitis C Virus Infection in Candidates for Liver Transplant With Cryptogenic Cirrhosis

(2013) Hossein Keyvani et al.   Hepatitis Monthly

TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation

(2013) A. Di Pietro et al.   JOURNAL OF VIROLOGY

Real Response to Therapy in Chronic Hepatitis C Virus Patients: A Study From Iran

(2012) Najmeh Namazee et al.   Hepatitis Monthly

Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins

(2011) Taro Kawai et al.   EMBO Molecular Medicine

Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease

(2011) Farah Bokharaei-Salim et al.   JOURNAL OF MEDICAL VIROLOGY

ENCODE Tiling Array Analysis Identifies Differentially Expressed Annotated and Novel 5′ Capped RNAs in Hepatitis C Infected Liver

(2011) Milan E. Folkers et al.   PLoS One

Tripartite-motif proteins and innate immune regulation

(2010) Finlay W McNab et al.   CURRENT OPINION IN IMMUNOLOGY

Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C

(2010) Masao Honda et al.   GASTROENTEROLOGY

Association of TRIM22 with the Type 1 Interferon Response and Viral Control during Primary HIV-1 Infection

(2010) R. Singh et al.   JOURNAL OF VIROLOGY

Peginterferon α-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases

(2010) Seyed-Moayed Alavian et al.   LIVER INTERNATIONAL

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin

(2010) Tarik Asselah et al.   LIVER INTERNATIONAL

Cell-Type Specific Gene Expression Signature in Liver Underlies Response to Interferon Therapy in Chronic Hepatitis C Infection

(2009) Limin Chen et al.   GASTROENTEROLOGY

Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain

(2009) Bo Gao et al.   HEPATOLOGY

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

(2009) Alfredo Alberti   LIVER INTERNATIONAL

Gene expression and hepatitis C virus infection

(2008) T Asselah et al.   GUT

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

(2008) Shunsuke Ura et al.   HEPATOLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Interferon signaling and treatment outcome in chronic hepatitis C

(2008) M. Sarasin-Filipowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA